Chapter: 1 Introduction
1.1 Report description
1.2 Key benefits
1.3 Key market trends
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
Chapter: 2 Executive summary
2.1 CXO perspective
Chapter: 3 Market Overview
3.1 Market definition and scope
3.2 Key Findings
3.2.1 Top Investment Pockets
3.2.2 Top Winning Strategies
3.3 Porters Five Forces Analysis
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of New Entrants
3.3.4 Threat of Substitutes
3.3.5 Competitive Rivalry
3.3.6 Top Player Positioning
3.4 Regulatory Scenario
3.4.1 U.S. FDA
3.4.2 Europe CE Mark
3.4.3 Ministry of Health, Labour and Welfare (MHLW)
3.5 Market dynamics
3.5.1 Drivers
3.5.1.1 growth in sales of Medical Implants and Devices
3.5.1.2 Rise in Number of FDA Approvals for Performing Clinical Trials to Benefit the Market
3.5.2 Restraints
3.5.2.1 Price volatility and supply constraints
3.5.2.2 Stringent approval process
3.5.3 Opportunities
3.5.3.1 Funding and grants create market opportunities worldwide
Chapter: 4 World medical ceramics market, by type
4.1 Introduction
4.1.1 Market Size and Forecast
4.2 Bioinert
4.2.1 Key markets trend
4.2.2 Key growth factors and opportunity
4.2.3 Market Size and Forecast
4.3 Bioactive
4.3.1 Key markets trends
4.3.2 Key growth factors and opportunity
4.3.3 Market Size and Forecast
4.4 Bioresorbable
4.4.1 Key markets trend
4.4.2 Key growth factors and opportunity
4.4.3 Market Size and Forecast
4.5 Piezo Ceramics
4.5.1 Key markets trend
4.5.2 Key growth factors and opportunity
4.5.3 Market Size and Forecast
Chapter: 5 World medical ceramics market, by application
5.1 Introduction
5.1.1 Market size and forecast
5.2 Devices
5.2.1 Market size and forecast
5.2.1.1 Surgical instruments
5.2.1.1.1 Market size and forecast
5.2.1.2 Diagnostics equipment
5.2.1.2.1 Market size and forecast
5.2.1.3 Others
5.2.1.3.1 Market size and forecast
5.3 Implants
5.3.1 Market size and forecast
5.3.1.1 Orthopedic implants
5.3.1.1.1 Market size and forecast
5.3.1.2 Electronic implants
5.3.1.2.1 Market size and forecast
5.3.1.3 Dental implants
5.3.1.3.1 Market size and forecast
5.4 Disposables
5.4.1 Market size and forecast
5.5 Packaging
5.5.1 Market size and forecast
Chapter: 6 World medical ceramics market, by geography
6.1 Introduction
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 U. S.
6.2.4.1 Market size and forecast
6.2.5 Canada
6.2.5.1 market size and forecast
6.2.6 Mexico
6.2.6.1 market size and forecast
6.3 Europe
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Germany
6.3.2.1 Market size and forecast
6.3.3 Franceze and forecast
6.3.4 UK
6.3.4.1 market size and forecast
6.3.1 Rest of Europe
6.3.1.1 market size and forecast
6.4 Asia-Pacific
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Japan
6.4.4.1 Market size and forecast
6.4.5 China
6.4.5.1 market size and forecast
6.4.6 India
6.4.6.1 market size and forecast
6.4.7 Rest of Asia-Pacific
6.4.7.1 market size and forecast
6.5 LAMEA
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Latin America
6.5.4.1 Market size and forecast
6.5.5 Middle East
6.5.5.1 market size and forecast
6.5.6 Africa
6.5.6.1 market size and forecast
Chapter: 7 Company profiles
7.1 3M ESPE
7.1.1 Company Overview
7.1.2 Operating business segments
7.1.3 Business performance
7.1.4 Key strategic moves & developments
7.2 CoorsTek Inc.
7.2.1 Company Overview
7.2.2 Operating business segments
7.2.3 Key strategic moves & developments
7.3 DePuy Synthes
7.3.1 Company Overview
7.3.2 Operating business segments
7.3.3 Business performance
7.3.4 Key strategic moves & developments
7.4 H.C. Starck GmbH
7.4.1 Company Overview
7.4.2 Operating business segments
7.4.3 Business performance
7.4.4 Key strategic moves & developments
7.5 Kyocera Corporation
7.5.1 Company Overview
7.5.2 Operating business segments
7.5.3 Business performance
7.5.4 Key strategic moves & developments
7.6 Morgan Advanced Materials
7.6.1 Company Overview
7.6.2 Operating business segments
7.6.3 Business performance
7.6.4 Key strategic moves & developments
7.7 Nobel Biocare Services AG
7.7.1 Company Overview
7.7.2 Operating business segments
7.7.3 Business performance
7.7.4 Key strategic moves & developments
7.8 Straumann
7.8.1 Company Overview
7.8.2 Operating business segments
7.8.3 Business performance
7.8.4 Key strategic moves & developments
7.9 Stryker
7.9.1 Company Overview
7.9.2 Operating business segments
7.9.3 Business performance
7.9.4 Key strategic moves & developments
7.10 Zimmer Biomet
7.10.1 Company Overview
7.10.2 Operating business segments
7.10.3 Business performance
7.10.4 Key strategic moves & developments